Reds place OF Austin Hays on the 10-day IL with bruised left foot

CHICAGO (AP) — The Cincinnati Reds placed outfielder Austin Hays on the 10-day injured list on Friday because of a left foot contusion.
The Reds also activated outfielder Jake Fraley from the 10-day IL before their series opener against the Chicago Cubs. Right-hander Lyon Richardson was recalled from Triple-A Louisville.
Hays, who turns 30 on July 5, got hurt when he fouled a pitch off his foot in the sixth inning of Wednesday's 3-2 loss at Kansas City. He missed the start of the season with a left calf strain and also spent time on the IL with a left hamstring strain.
Hays signed a $5 million, one-year contract with the Reds in January. He is batting .303 with six homers and 25 RBIs in 31 games this season.
Fraley, 30, got the start in right field for the series opener against Chicago. He had been sidelined by left calf tenderness.
Richardson is replacing Luis Mey, who was sent down on Thursday. The 25-year-old Richardson is 0-1 with a 1.32 ERA in 10 games with the Reds this season.
___
AP MLB: https://apnews.com/MLB

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

USA Today

18 minutes ago

• USA Today

Gavin Lux Player Props: June 22, Reds vs. Cardinals

Gavin Lux went hitless in his last game (0 for 4 with an RBI), but will have another crack at it when the Cincinnati Reds face Miles Mikolas and the St. Louis Cardinals on Sunday at 2:15 p.m. ET on FDSMW and FDSOH. Find odds, stats, and more below to make your Gavin Lux player prop bets. Lux is batting .265 with 14 doubles, a triple, three home runs and 32 walks. Watch tonight's Reds game on Fubo! Gavin Lux Prop Bets and Odds How to Watch Cincinnati Reds vs. St. Louis Cardinals Gavin Lux vs. Miles Mikolas Gavin Lux prop bet insights MLB odds courtesy of BetMGM Sportsbook. Odds updated Sunday at 1:28 p.m. ET. For a full list of sports betting odds, access USA TODAY Sports Betting Scores Odds Hub. Gavin Lux stats against the Cardinals Cardinals starter: Miles Mikolas

Medscape

18 minutes ago

• Medscape

Fewer ECG Abnormalities in Early T2D With Combo Therapy

TOPLINE: In patients with type 2 diabetes (T2D) of less than 10 years' duration who were taking metformin monotherapy, ECG abnormalities — including evidence of cardiovascular autonomic neuropathy — were common and associated with cardiovascular risk factors. After adding one of four frequently used glucose-lowering agents to metformin, fewer major ECG changes occurred with liraglutide than with the other treatments. METHODOLOGY: Researchers aimed to examine ECG abnormalities and cardiovascular autonomic neuropathy across the different glucose-lowering treatment groups in 5029 participants (mean age, 57.2 years; diabetes duration, 4.2 years; A1c level, 7.5%; 36.4% women) from the GRADE trial. The participants had T2D for less than 10 years and were initially taking metformin monotherapy before being randomly assigned to receive metformin plus one of four commonly used glucose-lowering agents (insulin glargine, glimepiride, liraglutide, or sitagliptin). Patients were followed up for an average of 5 years. Resting ECGs were recorded at baseline and at 2‐ and 4‐year follow-ups and analyzed for overall, major, and minor abnormalities, as well as heart rate variability — a measure of cardiovascular autonomic neuropathy. TAKEAWAY: More than half of participants in the GRADE trial had ECG abnormalities (57.1%) and ECG-defined cardiovascular autonomic neuropathy (52.8%) at baseline. The presence of these abnormalities was associated with longer diabetes duration, higher systolic blood pressure, greater prevalence of hyperlipidemia, more frequent use of lipid-lowering treatment, and beta-blocker use. Major ECG abnormalities occurred less frequently in the liraglutide group than in the other treatment groups (9% vs 13% at 4 years). Researchers found no significant differences in ECG-defined cardiovascular autonomic neuropathy between the liraglutide and non-liraglutide groups at 2 and 4 years (P = .42). IN PRACTICE: "ECG abnormalities, including those of CAN [cardiovascular autonomic neuropathy], are common in T2D < 10 years and are associated with certain CV [cardiovascular] risk factors. The development of major ECG abnormalities may differ by glucose-lowering treatment, as fewer occurred with liraglutide vs the other treatments," the authors concluded. SOURCE: The study was led by Rodica Pop-Busui, MD, PhD, Oregon Health & Science University in Portland. The results were presented on June 20 at the American Diabetes Association (ADA) 85th Scientific Sessions, being held June 20-23 at the McCormick Place Convention Center in Chicago, Illinois. LIMITATIONS: This abstract did not discuss any limitations. DISCLOSURES: Some authors disclosed receiving research support, consulting fees; serving on boards, advisory panels; being stock/shareholders; or other relationships with pharmaceutical and diagnostics companies and institutions. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Yahoo

18 minutes ago

• Yahoo

Houston Rockets have second-best NBA title odds at sportsbooks after Kevin Durant trade

Before Game 7 of this year's NBA Finals tipped off, the NBA world was stunned by a Kevin Durant blockbuster deal, sending him to the Houston Rockets for Jalen Green, Dillon Brooks, the No. 10 pick in next week's 2025 NBA draft and five second-round picks. It also sent a shockwave through the odds board at sportsbooks, as the Rockets moved from the 12-1 range to around +750 to win the 2025-26 NBA championship. Those are the consensus second-best odds behind the Oklahoma City Thunder, who are well ahead of any other team at +230. Advertisement "Good trade for Phoenix, adding Jalen Green and the 10th pick is the right direction," Jeff Sherman, vice president of risk at the Westgate Las Vegas SuperBook told Yahoo Sports via text message. "We lowered Houston from 12-1 to +900 just based on perception. They should be in the mix no doubt, I just like the return for Phoenix better than what the Rockets got in a 37-year-old they have to extend." The New York Knicks (+900), Indiana Pacers (+950) and Cleveland Cavaliers (11-1) had the next-best consensus title odds at sportsbooks. "Having someone who can score in the half court was exactly what Houston was lacking all season, and it cost them dearly in the playoffs," Thomas Gable, sportsbook director at The Borgata in Atlantic City (a BetMGM book) told Yahoo Sports via text. "While this will be Durant's 18th season, he can still generate offense in the half court, even if he doesn't get to the basket as much as he used to. He should help a very young Rockets team, even if it's only a short stint." Advertisement Sherman and other oddsmakers did have Houston as the second-best team in the West in their power ratings, but cautioned the ranking was simply as of today's trade, noting, for example, if San Antonio traded for Giannis Antetokounmpo that could vault them to No. 2. "We slightly lowered the Rockets' title odds," Jeff Benson, director of sportsbook operations at Circa Sports said via direct message on X. "They upgraded and didn't give up a ton, especially the good young guys." The +750 odds are the best for the Rockets since the 2019 season, per Sports Odds History, when Houston was +700.